ESPR vs POOL · rev $332.3M vs P/E 18, rev $5.31B
Esperion Therapeutics Inc (ESPR) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
ESPR currently screens at market cap $816.9M. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the ESPR and POOL stock pages for the full models.
Not investment advice.